13 May 2025 : Original article
Post-Liver Transplantation Atrial Fibrillation: Insights into Clinical and ECG Predictors
Özge ÇetinarslanDOI: 10.12659/AOT.948243
Ann Transplant 2025; 30:e948243
Table 2 Comparison of basal ECG, echocardiography parameters, and postoperative outcomes between study groups.
| Parameter | POAF group (n: 38) | Non-POAF group (n: 72) | P value |
|---|---|---|---|
| Heart rate (bpm) | 81.16±18.62 | 65.11±12.47 | <0.01* |
| QRS duration (ms) | 95.79±14.06 | 87.72±11.86 | <0.05* |
| Maximal P-wave duration (ms) | 126.84±15.29 | 109.72±21.71 | <0.01* |
| Minimal P-wave duration (ms) | 66.05±18.00 | 56.86±16.39 | 0.07 |
| PWPT-II | 61.05±13.29 | 49.71±18.98 | <0.05* |
| PWPT-V1 | 20.79±6.29 | 24.31±10.43 | 0.13 |
| PR interval (ms) | 169.47±20.41 | 145.06±33.99 | <0.01* |
| QTc interval (ms) | 458.05±39.64 | 423.86±32.48 | <0.01* |
| LVEF (%) | 59.0±3.91% | 60.73±1.27% | 0.13 |
| LVDd (mm) | 47.5±2.7 | 48.9±3.0 | 0.1 |
| LA diameter (mm) | 40.2±4.2 | 42.2±2.6 | 0.06 |
| sPAP (mmHg) | 28.26±2.83 | 27.03±4.86 | 0.3 |
| Post-op creatinine (mg/dL) | 1.23±0.54 | 1.14±0.5 | 0.41 |
| Post-op renal failure (%) | 26.3% | 11.1% | 0.57 |
| Post-op malignancy (%) | 18.0% | 12.0% | 0.12 |
| In-hospital mortality (%) | 38.8% | 8.3% | <0.01* |
| POAF – postoperative atrial fibrillation; ECG – electrocardiogram;PWPT – P-wave peak time; LVEF – left ventricular ejection fraction; LVDd – left ventricular diastolic diameter; LA – left atrium; sPAP – systolic pulmonary artery pressure. | |||






